中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2015年
8期
75-77
,共3页
芦鹏飞%刘晶%尹立勇%张亚杰%王玉琳%崔志杰
蘆鵬飛%劉晶%尹立勇%張亞傑%王玉琳%崔誌傑
호붕비%류정%윤립용%장아걸%왕옥림%최지걸
双联抗血小板药物%急性脑梗死%S100β%IL-1β%脂联素%神经功能评分
雙聯抗血小闆藥物%急性腦梗死%S100β%IL-1β%脂聯素%神經功能評分
쌍련항혈소판약물%급성뇌경사%S100β%IL-1β%지련소%신경공능평분
dual antiplatelet drugs%acute cerebral infarction%S100βprotein%IL-1β%adiponectin%NIHSS score
目的:探讨双联抗血小板药物对急性脑梗死患者血清S100β蛋白、白细胞介素1β( IL-1β)、脂联素( ADPN)及神经功能评分( NIHSS)的影响。方法收集河北省秦皇岛市第一医院收治的急性脑梗死患者58例,按照随机数字表分为对照组和实验组,每组各29例,均给予改善脑血管循环、保护脑细胞、控制血压、血糖、必要时吸氧等常规治疗。对照组在常规治疗基础上给予阿司匹林200 mg,1次/天,口服治疗;实验组在对照组治疗基础上加用氯吡格雷75 mg,1次/天,口服治疗,均治疗2周。治疗结束后,对所有患者的血清S100β蛋白、IL-1β、ADPN水平及NIHSS评分进行检测。结果与对照组比较,治疗后实验组患者的血清S-100β蛋白水平显著降低(P<0.05),血清IL-1β水平显著降低(P<0.05),血清ADPN水平显著升高(P<0.05),NIHSS评分显著降低(P<0.05)。结论双联抗血小板药物能够降低急性脑梗死患者血清中S-100β蛋白和IL-1β水平,提高ADPN水平,降低NIHSS评分,能够有效改善患者的神经功能。
目的:探討雙聯抗血小闆藥物對急性腦梗死患者血清S100β蛋白、白細胞介素1β( IL-1β)、脂聯素( ADPN)及神經功能評分( NIHSS)的影響。方法收集河北省秦皇島市第一醫院收治的急性腦梗死患者58例,按照隨機數字錶分為對照組和實驗組,每組各29例,均給予改善腦血管循環、保護腦細胞、控製血壓、血糖、必要時吸氧等常規治療。對照組在常規治療基礎上給予阿司匹林200 mg,1次/天,口服治療;實驗組在對照組治療基礎上加用氯吡格雷75 mg,1次/天,口服治療,均治療2週。治療結束後,對所有患者的血清S100β蛋白、IL-1β、ADPN水平及NIHSS評分進行檢測。結果與對照組比較,治療後實驗組患者的血清S-100β蛋白水平顯著降低(P<0.05),血清IL-1β水平顯著降低(P<0.05),血清ADPN水平顯著升高(P<0.05),NIHSS評分顯著降低(P<0.05)。結論雙聯抗血小闆藥物能夠降低急性腦梗死患者血清中S-100β蛋白和IL-1β水平,提高ADPN水平,降低NIHSS評分,能夠有效改善患者的神經功能。
목적:탐토쌍련항혈소판약물대급성뇌경사환자혈청S100β단백、백세포개소1β( IL-1β)、지련소( ADPN)급신경공능평분( NIHSS)적영향。방법수집하북성진황도시제일의원수치적급성뇌경사환자58례,안조수궤수자표분위대조조화실험조,매조각29례,균급여개선뇌혈관순배、보호뇌세포、공제혈압、혈당、필요시흡양등상규치료。대조조재상규치료기출상급여아사필림200 mg,1차/천,구복치료;실험조재대조조치료기출상가용록필격뢰75 mg,1차/천,구복치료,균치료2주。치료결속후,대소유환자적혈청S100β단백、IL-1β、ADPN수평급NIHSS평분진행검측。결과여대조조비교,치료후실험조환자적혈청S-100β단백수평현저강저(P<0.05),혈청IL-1β수평현저강저(P<0.05),혈청ADPN수평현저승고(P<0.05),NIHSS평분현저강저(P<0.05)。결론쌍련항혈소판약물능구강저급성뇌경사환자혈청중S-100β단백화IL-1β수평,제고ADPN수평,강저NIHSS평분,능구유효개선환자적신경공능。
Objective To analyse the effect of dual-antiplatelet drugs on S100β,IL-1β, adiponectin(ADPN)and NIHSS score in patients with acute cerebral infarction.Methods 58 patients diagnosed with acute cerebral infarction in first hospital of Qinhuangdao.All patients were collected and randomly divided into experimental group and control group according to random number table , 29 cases in each group.Both group were given the treatrnent of improvng the cerebral vascular circulation, protect brain cells, control blood pressure, blood glucose, oxygen when necessary.On the basis of conventional treatment, control group was treated with aspirin 200 mg, one time per day,orally.And experimental group was treated with clopidogrel 75 mg/d on the basis of control group,one time per day,orally.After treatment, the serum levels of S100β, IL-1β, ADPN and NIHSS score were detected in all patients.ResuIts After treatment, compared with control group,the serum S100βprotein level was significantly lower in the experimental group (P<0.05); the serum IL-1βlevel in experimental group was significantly lower (P<0.05);ADPN level in experimental group was significantly higher (P<0.05); NIHSS score of patients in experimental group was significantly lower (P<0.05).ConcIusions Dual antiplatelet drugs can reduce serum S100βprotein,IL-1βin serum of patients with acute cerebral infarction, increase the level of serum adiponectin, decrease NIHSS score, can effectively improre neurological function in patients with acute cerebral infarction.